BioHealth News Archive
Georgetown Ranks Second Among Top Universities in Women Graduates Who Enter Venture Capital
Georgetown University ranks second among the nation’s colleges and universities in graduating women who go on to lead venture capital firms, according to a…
Read More
Phlow Corp. and USP announce strategic alliance focused on Pharmaceutical Continuous Manufacturing to increase supply of essential medicines for U.S. patients
Richmond, VA., February 22, 2021 – Phlow Corp., a public benefit essential medicines solutions provider, and the United States Pharmacopeia (USP) today announced a…
Read More
VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-19, 2021 (2)
Don’t miss a unique opportunity to discuss your biohealth technology innovation directly with Program Officers from NSF, various institutes at NIH, the University of…
Read More
VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-18, 2021
Don’t miss a unique opportunity to discuss your biohealth technology innovation directly with Program Officers from NSF, various institutes at NIH (including NIA, NCI,…
Read More
2/28 Deadline to Apply for $ (oncology innovation)…
for The Rockville-based National Foundation for Cancer Research is accepting applications through Sunday evening, February 28, from academic laboratory and early stage start-up-based promising…
Read More
Salisbury Award for Entrepreneurial Translational Research – NFCR
The National Foundation for Cancer Research is proud to present the Salisbury Award in honor of the Salisbury family’s vision and legacy of funding…
Read More
Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer – Cartesian
Gaithersburg, MD, Feb. 22, 2021 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company pioneering mRNA-engineered cell therapy in and beyond oncology, today announced that…
Read MoreNovavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico | Novavax Inc. – IR Site
GAITHERSBURG, Md., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced…
Read More
Eyedea Medical Joins Baltimore’s LaunchPort™ Medtech Venture Center
The LaunchPort™ announced today that Eyedea Medical (https://www.eyedeamedical.com/) joined the Venture Center and will make the Port Covington, Baltimore location their HQ and engineering…
Read More
John Mumm, CEO of Deka BioSciences, joins Rich Bendis on BioTalk
Deka BioSciences CEO, John Mumm, CEO of Deka BioSciences, virtually guests on BioTalk to discuss his history in the BioHealth Capital Region, Precision Medicine,…
Read MoreMaryland Today | Pandemic Fighter’s Priorities
One of the nation’s leading scientists in the desperate campaign to develop coronavirus vaccines—and in the Hollywood-esque triumph of succeeding within a year—grew up…
Read More
5 Questions with Paul Nolde, Fund Manager/Managing Director, Riverflow Growth Fund · BioBuzz
“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little…
Read More
Novavax Expands COVID-19 Collaboration and License Agreement with SK Bioscience | BioPharm International
On Feb. 15, 2021, biotechnology company Novavax and SK Bioscience, a vaccine business subsidiary of SK Group, announced an expanded collaboration and license agreement…
Read More
Internship pipeline helps close the equity gap during pandemic | Hub
Lubna Azmi sees herself as a laidback person, but even she isn't immune to the pressures and anxieties that come with planning for the…
Read More
AstraZeneca’s Joe Sanchez Shares Vision for Growing the BioHealth Capital Region · BioBuzz
When AstraZeneca (AZ) announced in 2019 that it was officially retiring the MedImmune brand, questions naturally arose about whether the U.K. pharma giant would…
Read More